Specialty Drug Distribution Market Analysis By Drug Type & By Distribution 2020 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Specialty drug distribution market
Specialty Drug Distribution Market Analysis: By Drug Type (Oncology, Multiple Sclerosis, Rheumatoid Arthritis, Hemophilia); By Distribution (Retail, Home Health, Clinics, Pharmacies) - Forecast (2015 - 2020)
Report Code : HCR 0051
Published: 27 June, 2015   No. of pages: 180

  • Report Description
  • Table of Contents
  • Customization Options
Specialty Drugs are used to treat chronic diseases such as Cancer, Multiple Sclerosis and Rheumatoid Arthritis. Specialty Drugs are injectable, oral or inhaled in nature which are prescribed by the physician for special cases. Specialty Drugs is one of the fastest growing category in the Pharmaceutical market. The Specialty Drug Distribution market will see steady growth, accounting for the fact that the use of Specialty Drugs is increasing.

The Specialty Drugs Distribution Market is estimated to be $500 million in 2015. It is estimated to grow at a CAGR of 18% between 2015-2020. The driving force behind the growth is Healthcare reforms, transition in Payer dynamics and growth of Specialty Drugs. The Specialty Drug Distribution market is Oligopolistic in nature with three players dominating the market with different pricing strategies. Such a scenario creates barriers for new entrants into the market. The companies follow a pricing discount strategy which acts as a leverage for gaining market share. There are other factors such as excellent logistics, efficient supply chain and unparalleled warehousing facilities which has kept the market growing at a fast pace.

The North America region is leading the market share geographically due to better healthcare reforms, increased use of Specialty Drugs to treat chronic diseases, better distribution facilities. The European region is slowly gaining the market share in the Specialty Drug Distribution market. The vast geographical landscape in Europe serves as a major challenge in having an efficient distribution & logistics network. The highest growth is going to be witnessed in Asia Pacific region, in countries such as India, China and Australia. The reason behind the growth is improving infrastructure, innovative distribution facilities.

The Specialty Drug Distribution market is also facing challenges which restricts the market to grow steadily. The channel restriction is one of the major issues at hand. Consumers in order to get the product at a cheaper price, try to bypass the distribution channel. This leads to counterfeiting. There is also a need to collect distribution data which will help in creating restricted access channels.

Market size and forecast is provided for each of these regions. A detailed qualitative analysis of the factors responsible for driving and restraining growth of the Specialty Drug Distribution market and future opportunities are provided in the report. This report on the Global Specialty Drug Distribution Market identifies many such insights and M&A opportunities, besides providing a detailed analysis of the Specialty Drug Distribution market.
1. Global Specialty Drug Distribution. - Market Overview
2. Executive Summary
3. Global Specialty Drug Distribution. - Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End user profiling
      3.2.3. Patent Analysis
      3.2.4. Top 5 Financials Analysis
4. Global Specialty Drug Distribution. - Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Industry
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Global Specialty Drug Distribution. Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Opportunities Analysis
   5.3. Product/Market Life Cycle Analysis
6. Global Specialty Drugs– By Application
   6.1. Oncology
   6.2. AIDS
   6.3. Multiple Sclerosis
   6.4. Rheumatoid Arthritis
   6.5. Hemophilia
   6.6. Others
7. Global Specialty Drug Distribution. Market – By Distribution Type
   7.1. Mail Delivery
   7.2. Outpatient
   7.3. Retail
   7.4. Home Health
   7.5. Clinic/ASCs
   7.6. Inpatient
8. Global Specialty Drug Distribution. Market – By Distribution Channel
   8.1. Full line Wholesalers
   8.2. Specialty Distributors
9. Global Specialty Drug Distribution. Market – By End User
   9.1. Independent Pharmacies
   9.2. Large Chain Pharmacies
   9.3. Hospitals
   9.4. Clinics/ASCs
10. Global Specialty Drug Distribution. Market - Geographic Analysis
   10.1. Introduction. 
   10.2. Americas
      10.2.1. Canada
      10.2.2. USA
      10.2.3. Brazil
      10.2.4. Others
   10.3. Europe
      10.3.1. U.K.
      10.3.2. Germany
      10.3.3. France
      10.3.4. Spain
      10.3.5. Netherlands
      10.3.6. Others
   10.4. APAC
      10.4.1. China
      10.4.2. Japan
      10.4.3. India
      10.4.4. South Korea
      10.4.5. Australia
      10.4.6. Others
   10.5. ROW
11. Market Entropy
   11.1. New Product Launches
   11.2. M&As, Collaborations, JVs and Partnerships
12. Company Profiles (Overview, Financials, Strategy, Developments, Product Portfolio)
   12.1. Mckesson Corporation
   12.2. Cardinal Health
   12.3. Amerisource Bergen
   12.4. Fastenal
   12.5. Cintas
   12.6. Grainger
   12.7. MSC Industrial
   12.8. Wal-Mart
   12.9. Morris & Dickson
   12.10. H.D. Smith
   12.11. Curascript Specialty Distribution
   12.12. Rochester Drug Cooperative
   12.13. Smith Drug
   12.14. NC Mutual Wholesale Drug
   12.15. Anda Distribution
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
13. Appendix
   13.1. Abbreviations
   13.2. Sources
   13.3. Research Methodology
   13.4. Bibliography
   13.5. Compilation of Expert Insights
14. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports